Deutsch English Français

Contact

EP2300501

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...

Extract from the Register of European Patents

EP About this file: EP2300501

EP2300501 - A POLYPEPTIDE COMPLEX COMPRISING NON-PEPTIDYL POLYMER HAVING THREE FUNCTIONAL ENDS [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 26.06.2015 Database last updated on 08.04.2026
Most recent event Tooltip	22.06.2018	Lapse of the patent in a contracting state New state(s): MK	published on 25.07.2018 [2018/30]
Applicant(s)	For all designated states Hanmi Science Co., Ltd. 550 Dongtangiheung-ro Dongtan-myeon Hwaseong-si Gyeonggi-do 445-813 / KR
	[2012/45]
Former [2011/13]	For all designated states Hanmi Holdings Co., Ltd. No. 45, Bangi-dong Songpa-gu Seoul 138-828 / KR
Inventor(s)	01 / SONG, Dae Hae 307-2403 Samsungsan Apt. Sillim 10-dong Gwanak-gu Seoul 151-704 / KR
	02 / SHIN, Jae Hee 318-1905 Woobang Apt. Jeongja 2-dong Jangan-gu Suwon-si Gyeonggi-do 440-302 / KR
	03 / LEE, Mi Ji 101-906 Daemyeong Apt. Yeonsu 1-dong Yeonsu-gu Incheon 406-111 / KR
	04 / HONG, Sung Hee 845-1002 Byeokjeokgol 8-danji Yeongtong-dong Yeongtong-gu Suwon-si Gyeonggi-do 443-470 / KR
	05 / KWON, Se Chang 10-1204 Keukdong Apt. Gwangjang-dong Gwangjin-gu Seoul 143-751 / KR
	06 / LEE, Gwan Sun 3-404 Wuchang Apt. Ogeum-dong Songpa-gu Seoul 138-739 / KR
	[2014/34]
Former [2011/13]	01 / SONG, Dae Hae 307-2403 Samsungsan Apt. Sillim 10-dong Gwanak-gu Seoul 151-704 / KR
	02 / SHIN, Jae Hee 318-1905 Woobang Apt. Jeongja 2-dong Jangan-gu Suwon-si Gyeonggi-do 440-302 / KR
	03 / LEE, Mi Ji 101-906 Daemyeong Apt. Yeonsu 1-dong Yeonsu-gu Incheon 406-111 / KR
	04 / HONG, Sung Hee 845-1002 Byeokjeokgol 8-danji Yeongtong-dong Yeongtong-gu Suwon-si Gyeonggi-do 443-470 / KR
	05 / KWON, Se Chang 10-1204 Keukdong Apt. Gwangjang-dong Gwangjin-gu Seoul 143-751 / KR
	06 / LEE, Gwan Sun 3-404 Wuchang Apt. Ogeum-dong Songpa-gu Seoul 138-739 / KR
Representative(s)	Mai Besier European Trademark Attorneys Patentanwälte Kreuzberger Ring 18a 65205 Wiesbaden / DE
	[N/P]
Former [2014/34]	Mai, Dörr, Besier Patentanwälte Steuerberater/Wirtschaftsprüfer Kreuzberger Ring 64 65205 Wiesbaden / DE
Former [2012/07]	Mai, Dörr, Besier Patentanwälte Steuerberater/Wirtschaftsprüfer John-F.-Kennedy-Straße 4 65189 Wiesbaden / DE
Former [2011/13]	Luderschmidt, Schüler & Partner Patentanwälte John-F.-Kennedy-Strasse 4 65189 Wiesbaden / DE
Application number, filing date	09800577.0	23.07.2009
	[2011/13]
	WO2009KR04114
Priority number, date	KR20080071766	23.07.2008 Original published format: KR 20080071766
	[2011/13]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2010011096
	Date:	28.01.2010
	Language:	EN
	[2010/04]
	Type:	A2 Application without search report
	No.:	EP2300501
	Date:	30.03.2011
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 28.01.2010 takes the place of the publication of the European patent application.
	[2011/13]
	Type:	B1 Patent specification
	No.:	EP2300501
	Date:	20.08.2014
	Language:	EN
	[2014/34]
Search report(s)	International search report - published on:	KR	27.05.2010
	(Supplementary) European search report - dispatched on:	EP	30.12.2011
Classification	IPC:	C07K19/00, A61K47/48	[2012/05]
	CPC:	A61K47/60 (EP,US); C07K19/00 (EP,KR,US); A61K38/00 (KR); A61K47/6811 (EP,US); A61K47/6889 (EP,US); A61P31/00 (EP); (+) A61P43/00 (EP); A61P5/00 (EP); A61P5/50 (EP); C07K14/59 (EP,US); C07K2319/31 (EP,US) (-)
	Former IPC [2011/13]	C07K19/00
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2011/13]
Title	German:	POLYPEPTIDKOMPLEX MIT EINEM NICHT-PEPTIDYL-POLYMER MIT DREI FUNKTIONALEN ENDEN	[2011/13]
	English:	A POLYPEPTIDE COMPLEX COMPRISING NON-PEPTIDYL POLYMER HAVING THREE FUNCTIONAL ENDS	[2011/13]
	French:	COMPLEXE DE POLYPEPTIDE COMPRENANT UN POLYMÈRE NON-PEPTIDYLIQUE AYANT TROIS EXTRÉMITÉS FONCTIONNELLES	[2011/13]
Entry into regional phase	11.01.2011	National basic fee paid
	11.01.2011	Search fee paid
	11.01.2011	Designation fee(s) paid
	11.01.2011	Examination fee paid
Examination procedure	11.01.2011	Examination requested [2011/13]
	03.07.2012	Amendment by applicant (claims and/or description)
	13.08.2012	Despatch of a communication from the examining division (Time limit: M04)
	15.11.2012	Reply to a communication from the examining division
	20.11.2013	Communication of intention to grant the patent
	13.03.2014	Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
	13.03.2014	Fee for grant paid
	13.03.2014	Fee for publishing/printing paid
	25.06.2014	Communication of intention to grant the patent
	09.07.2014	Fee for grant paid
	09.07.2014	Fee for publishing/printing paid
	09.07.2014	Receipt of the translation of the claim(s)
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 13.08.2012
Opposition(s)	21.05.2015	No opposition filed within time limit [2015/31]
Fees paid	Renewal fee
	26.07.2011	Renewal fee patent year 03
	30.07.2012	Renewal fee patent year 04
	30.07.2013	Renewal fee patent year 05
	28.05.2014	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	HU	23.07.2009
	AT	20.08.2014
	BE	20.08.2014
	CY	20.08.2014
	CZ	20.08.2014
	DK	20.08.2014
	EE	20.08.2014
	FI	20.08.2014
	HR	20.08.2014
	LT	20.08.2014
	LV	20.08.2014
	MC	20.08.2014
	MK	20.08.2014
	MT	20.08.2014
	NL	20.08.2014
	PL	20.08.2014
	RO	20.08.2014
	SI	20.08.2014
	SK	20.08.2014
	SM	20.08.2014
	TR	20.08.2014
	BG	20.11.2014
	NO	20.11.2014
	GR	21.11.2014
	IS	20.12.2014
	PT	22.12.2014
	[2018/30]
Former [2017/38]	HU	23.07.2009
	AT	20.08.2014
	BE	20.08.2014
	CY	20.08.2014
	CZ	20.08.2014
	DK	20.08.2014
	EE	20.08.2014
	FI	20.08.2014
	HR	20.08.2014
	LT	20.08.2014
	LV	20.08.2014
	MC	20.08.2014
	MT	20.08.2014
	NL	20.08.2014
	PL	20.08.2014
	RO	20.08.2014
	SI	20.08.2014
	SK	20.08.2014
	SM	20.08.2014
	TR	20.08.2014
	BG	20.11.2014
	NO	20.11.2014
	GR	21.11.2014
	IS	20.12.2014
	PT	22.12.2014
Former [2017/21]	AT	20.08.2014
	BE	20.08.2014
	CZ	20.08.2014
	DK	20.08.2014
	EE	20.08.2014
	FI	20.08.2014
	HR	20.08.2014
	LT	20.08.2014
	LV	20.08.2014
	MC	20.08.2014
	MT	20.08.2014
	NL	20.08.2014
	PL	20.08.2014
	RO	20.08.2014
	SI	20.08.2014
	SK	20.08.2014
	BG	20.11.2014
	NO	20.11.2014
	GR	21.11.2014
	IS	20.12.2014
	PT	22.12.2014
Former [2016/33]	AT	20.08.2014
	BE	20.08.2014
	CZ	20.08.2014
	DK	20.08.2014
	EE	20.08.2014
	FI	20.08.2014
	HR	20.08.2014
	LT	20.08.2014
	LV	20.08.2014
	MC	20.08.2014
	NL	20.08.2014
	PL	20.08.2014
	RO	20.08.2014
	SI	20.08.2014
	SK	20.08.2014
	BG	20.11.2014
	NO	20.11.2014
	GR	21.11.2014
	IS	20.12.2014
	PT	22.12.2014
Former [2016/13]	AT	20.08.2014
	CZ	20.08.2014
	DK	20.08.2014
	EE	20.08.2014
	FI	20.08.2014
	HR	20.08.2014
	LT	20.08.2014
	LV	20.08.2014
	MC	20.08.2014
	NL	20.08.2014
	PL	20.08.2014
	RO	20.08.2014
	SI	20.08.2014
	SK	20.08.2014
	BG	20.11.2014
	NO	20.11.2014
	GR	21.11.2014
	IS	20.12.2014
	PT	22.12.2014
Former [2015/50]	AT	20.08.2014
	CZ	20.08.2014
	DK	20.08.2014
	EE	20.08.2014
	FI	20.08.2014
	HR	20.08.2014
	LT	20.08.2014
	LV	20.08.2014
	NL	20.08.2014
	PL	20.08.2014
	RO	20.08.2014
	SI	20.08.2014
	SK	20.08.2014
	BG	20.11.2014
	NO	20.11.2014
	GR	21.11.2014
	IS	20.12.2014
	PT	22.12.2014
Former [2015/24]	AT	20.08.2014
	CZ	20.08.2014
	DK	20.08.2014
	EE	20.08.2014
	FI	20.08.2014
	HR	20.08.2014
	LT	20.08.2014
	LV	20.08.2014
	NL	20.08.2014
	PL	20.08.2014
	RO	20.08.2014
	SK	20.08.2014
	BG	20.11.2014
	NO	20.11.2014
	GR	21.11.2014
	IS	20.12.2014
	PT	22.12.2014
Former [2015/23]	AT	20.08.2014
	CZ	20.08.2014
	DK	20.08.2014
	EE	20.08.2014
	FI	20.08.2014
	HR	20.08.2014
	LT	20.08.2014
	LV	20.08.2014
	NL	20.08.2014
	RO	20.08.2014
	SK	20.08.2014
	BG	20.11.2014
	NO	20.11.2014
	GR	21.11.2014
	IS	20.12.2014
	PT	22.12.2014
Former [2015/22]	AT	20.08.2014
	DK	20.08.2014
	FI	20.08.2014
	HR	20.08.2014
	LT	20.08.2014
	LV	20.08.2014
	NL	20.08.2014
	RO	20.08.2014
	BG	20.11.2014
	NO	20.11.2014
	GR	21.11.2014
	IS	20.12.2014
	PT	22.12.2014
Former [2015/16]	AT	20.08.2014
	FI	20.08.2014
	HR	20.08.2014
	LT	20.08.2014
	LV	20.08.2014
	NL	20.08.2014
	BG	20.11.2014
	NO	20.11.2014
	GR	21.11.2014
	IS	20.12.2014
	PT	22.12.2014
Former [2015/12]	AT	20.08.2014
	FI	20.08.2014
	HR	20.08.2014
	LT	20.08.2014
	LV	20.08.2014
	BG	20.11.2014
	NO	20.11.2014
	GR	21.11.2014
	IS	20.12.2014
	PT	22.12.2014
Former [2015/11]	FI	20.08.2014
	LT	20.08.2014
	BG	20.11.2014
	NO	20.11.2014
	GR	21.11.2014
	PT	22.12.2014
Former [2015/10]	FI	20.08.2014
	LT	20.08.2014
	BG	20.11.2014
	NO	20.11.2014
Former [2015/09]	FI	20.08.2014
	LT	20.08.2014
Former [2015/08]	LT	20.08.2014
Documents cited:	Search	[I] WO9411399 (KLUGER RONALD et al.) [I] 1,11-14,16-19,21-27 * the whole document *
		[I] WO2007062177 (VENTANA MED SYST INC et al.) [I] 1,11-14,16-19,21-27 * example 17 *
		[I] WO9302105 (HYBRITECH INC et al.) [I] 1,11-14,16-19,21-27 * the whole document *
		[I] WO2004054615 (MITRA MEDICAL TECHNOLOGY AB et al.) [I] 1,11-14,16-19,21-27 * the whole document *
		[A] WO2008082274 (HANMI PHARMACEUTICAL CO LTD et al.) [A] 1-27
		[I] R. AHRENDS: "Identifying an interaction site between MutH and the C-terminal domain of MutL by crosslinking, affinity purification, chemical coding and mass spectrometry", NUCLEIC ACIDS RESEARCH, vol. 34, no. 10, 31 May 2006 (2006-05-31), pages 3169 - 3180, XP055015155, ISSN: 0305-1048, DOI: 10.1093/nar/gkl407 [I] 1,11-14,16-19,21-27 * the whole document * DOI: http://dx.doi.org/10.1093/nar/gkl407
		[I] C. A. STUDDERT: "Insights into the organization and dynamics of bacterial chemoreceptor clusters through in vivo crosslinking studies", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 102, no. 43, 25 October 2005 (2005-10-25), pages 15623 - 15628, XP055015176, ISSN: 0027-8424, DOI: 10.1073/pnas.0506040102 [I] 1,11-14,16-19,21-27 DOI: http://dx.doi.org/10.1073/pnas.0506040102
	International search	[X] N.C. TON ET AL.: "Phase I Evaluation of CDP791, a PEGylated Di-Fab' Conjugate that BindsVascular Endothelial Growth Factor Receptor 2", CANCER THERAPY: CLINICAL, vol. 13, no. 23, 1 December 2007 (2007-12-01), pages 7113 - 7118, XP009147881 [X] DOI: http://dx.doi.org/10.1158/1078-0432.CCR-07-1550
		[A] LOTTE DINESEN ET AL.: "'Targeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870)'", INTERNATIONAL JOURNAL OF NANOMEDICINE, vol. 2, no. 1, 2007, pages 39 - 47, XP008140393 [A]
	by applicant	KINSTLER ET AL., PHARMACEUTICAL RESEARCH, vol. 12, no. 12, 1995, pages 1883 - 1888
		OSBORN ET AL., J. PHAR. EXP. THER., vol. 303, no. 2, 2002, pages 540 - 548
		BURTON D., MOLEC. IMMUN, vol. 22, 1985, pages 161 - 206
		WALDMANN H., EUR. J. IMMUNOL., vol. 23, 1993, pages 403 - 411
		MORRISON S., J. IMMUNOL., vol. 143, 1989, pages 2595 - 2601
		H. NEURATH; R. L. HILL: "The Proteins", 1979, ACADEMIC PRESS

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.